Skip to main content
Top
Published in: Internal and Emergency Medicine 1/2014

01-02-2014 | IM - ORIGINAL

Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation

Authors: Ernesto Crisafulli, Elena Venturelli, Gianluca Biscione, Guido Vagheggini, Andrea Iattoni, Sasha Lucic, Nicolino Ambrosino, Franco Pasqua, Alfredo Cesario, Enrico Maria Clini

Published in: Internal and Emergency Medicine | Issue 1/2014

Login to get access

Abstract

The role of pulmonary rehabilitation (PR) in COPD patients with lung hyperinflation has not yet been fully investigated. We retrospectively evaluated the effect of a standard PR course on exercise tolerance and symptoms according to the presence or absence of associated lung hyperinflation, as defined by lung function parameters in three Italian rehabilitation centres. In a cohort of 823 COPD patients (age 71 ± 8 years, FEV1 56 ± 18% pred.) we have systematically recorded: changes (∆) in 6-minute walking test (6MWD) as the primary outcome; dyspnoea (D); muscle fatigue (F); SO2nadir during effort; perceived breathlessness score (MRC); and specific health-related quality of life (SGRQ). Outcomes were compared between patients with lung hyperinflation (n = 283, LH) or without (n = 540 No-LH). Groups were comparable for age, body mass index, baseline exercise tolerance, and breathlessness. ∆-6MWD (+72 ± 47 vs. +62 ± 42 m, p < 0.05); ∆-D (−2.3 ± 1.7 vs. −1.9 ± 1.3 point, p < 0.05) and ∆-SO2nadir (+1.4 ± 3.0 and +0.5 ± 3.3 point, p < 0.05) were greater in LH than in No-LH. Using a multivariate linear regression model, ∆-6MWD in the LH group significantly correlated with lower functional residual capacity (p = 0.021) and baseline 6MWD (p = 0.004). Tolerance, gas exchange and perceived symptoms during effort are the parameters that gain a significant benefit from standard rehabilitation in COPD patients with a lung hyperinflation condition.
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Pulmonary Disease (2006) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report, NIH Publication 2701. http://www.goldcopd.com (last accessed March 2011) Global Initiative for Chronic Obstructive Pulmonary Disease (2006) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO workshop report, NIH Publication 2701. http://​www.​goldcopd.​com (last accessed March 2011)
2.
go back to reference Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS (1966) The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet 1:830–835PubMedCrossRef Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS (1966) The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet 1:830–835PubMedCrossRef
3.
go back to reference Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, Marchesi C, Giuntini C (2008) Identification of a predominant COPD phenotype in clinical practice. Respir Med 102:367–376PubMedCrossRef Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, Marchesi C, Giuntini C (2008) Identification of a predominant COPD phenotype in clinical practice. Respir Med 102:367–376PubMedCrossRef
4.
go back to reference Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, Pozzi E (2004) Assessment of emphysema in COPD: a functional and radiologic study. Chest 125:1714–1718PubMedCrossRef Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, Pozzi E (2004) Assessment of emphysema in COPD: a functional and radiologic study. Chest 125:1714–1718PubMedCrossRef
5.
go back to reference Casaburi R, ZuWallack R (2009) Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 360:1329–1335PubMedCrossRef Casaburi R, ZuWallack R (2009) Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 360:1329–1335PubMedCrossRef
6.
go back to reference Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134:273–280PubMedCrossRef Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134:273–280PubMedCrossRef
7.
go back to reference Crisafulli E, Gorgone P, Vagaggini B, Pagani M, Rossi G, Costa F, Guarriello V, Paggiaro P, Chetta A, de Blasio F, Olivieri D, Fabbri LM, Clini EM (2010) Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J36:1042–1048CrossRef Crisafulli E, Gorgone P, Vagaggini B, Pagani M, Rossi G, Costa F, Guarriello V, Paggiaro P, Chetta A, de Blasio F, Olivieri D, Fabbri LM, Clini EM (2010) Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J36:1042–1048CrossRef
8.
go back to reference Clini EM, Crisafulli E, Costi S, Rossi G, Lorenzi C, Fabbri LM, Ambrosino N (2009) Effects of early inpatient rehabilitation after acute exacerbation of COPD. Respir Med 103:1526–1531PubMedCrossRef Clini EM, Crisafulli E, Costi S, Rossi G, Lorenzi C, Fabbri LM, Ambrosino N (2009) Effects of early inpatient rehabilitation after acute exacerbation of COPD. Respir Med 103:1526–1531PubMedCrossRef
9.
go back to reference Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP, National Emphysema Treatment Trial Research Group (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128:3799–3809PubMedCrossRef Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP, National Emphysema Treatment Trial Research Group (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128:3799–3809PubMedCrossRef
10.
go back to reference (2006) American Thoracic Society/European Respiratory Society Statement On Pulmonary Rehabilitation. Am J Respir Crit Care Med 173:1390–1413 (2006) American Thoracic Society/European Respiratory Society Statement On Pulmonary Rehabilitation. Am J Respir Crit Care Med 173:1390–1413
11.
go back to reference Clini E, Costi S, Romagnoli M, Florini F (2004) Rehabilitation of COPD patients: which training modality. Monaldi Arch Chest Dis 61:167–173PubMed Clini E, Costi S, Romagnoli M, Florini F (2004) Rehabilitation of COPD patients: which training modality. Monaldi Arch Chest Dis 61:167–173PubMed
12.
go back to reference Charlson M, Szatrowski TP, Peterson J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251PubMedCrossRef Charlson M, Szatrowski TP, Peterson J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251PubMedCrossRef
13.
go back to reference Quanjer PH (1983) Working party on “Standardization of lung function test”. Bull Eur Physiopathol Respir 19(Suppl 5):7–10 Quanjer PH (1983) Working party on “Standardization of lung function test”. Bull Eur Physiopathol Respir 19(Suppl 5):7–10
14.
go back to reference American Thoracic Society (2002) American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef American Thoracic Society (2002) American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef
15.
go back to reference Borg G (1982) Psychophysical basis of perceived exertion. Med Sci Sports Exerc 14:31–37 Borg G (1982) Psychophysical basis of perceived exertion. Med Sci Sports Exerc 14:31–37
16.
go back to reference Fletcher CM (1960) Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of chronic bronchitis (MRC breathlessness score). Br Med J 2:1665 Fletcher CM (1960) Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of chronic bronchitis (MRC breathlessness score). Br Med J 2:1665
17.
go back to reference Carone M, Bertolotti G, Anchisi F, Zotti AM (1999) The St George’s respiratory questionnaire (SGRQ): Italian version. Rassegnadi Patologiadell’ Apparato Respiratorio 14:31–37 Carone M, Bertolotti G, Anchisi F, Zotti AM (1999) The St George’s respiratory questionnaire (SGRQ): Italian version. Rassegnadi Patologiadell’ Apparato Respiratorio 14:31–37
18.
go back to reference Make B, Casaburi R, Kline Leidy N (2005) Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcome. COPD 2:1–5PubMedCrossRef Make B, Casaburi R, Kline Leidy N (2005) Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcome. COPD 2:1–5PubMedCrossRef
19.
go back to reference Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH (1997) Interpreting small differences in functional status: the six-minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 155:1278–1282PubMedCrossRef Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH (1997) Interpreting small differences in functional status: the six-minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 155:1278–1282PubMedCrossRef
20.
go back to reference DeTorres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121:1092–1098CrossRef DeTorres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B (2002) Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest 121:1092–1098CrossRef
21.
go back to reference Giustino G, Webb KA, Sutherland KB, O’Donnell DE (1999) Severe exertional dyspnea in a patient with localized emphysema. Can Respir J 6:535–539PubMed Giustino G, Webb KA, Sutherland KB, O’Donnell DE (1999) Severe exertional dyspnea in a patient with localized emphysema. Can Respir J 6:535–539PubMed
22.
go back to reference Boschetto P, Miniati M, Miotto D, Braccioni F, De Rosa E, Bononi I, Papi A, Saetta M, Fabbri LM, Mapp CE (2003) Predominant emphysema phenotype in chronic obstructive pulmonary disease patients. Eur Respir J 21:450–454PubMed Boschetto P, Miniati M, Miotto D, Braccioni F, De Rosa E, Bononi I, Papi A, Saetta M, Fabbri LM, Mapp CE (2003) Predominant emphysema phenotype in chronic obstructive pulmonary disease patients. Eur Respir J 21:450–454PubMed
23.
go back to reference Burrows B, Bloom JW, Traver GA, Cline MG (1987) The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 317:1309–1314PubMedCrossRef Burrows B, Bloom JW, Traver GA, Cline MG (1987) The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 317:1309–1314PubMedCrossRef
24.
go back to reference Burrows B, Earle RH (1969) Prediction of survival in patients with chronic airways obstruction. Am Rev Respir Dis 99:865–871PubMed Burrows B, Earle RH (1969) Prediction of survival in patients with chronic airways obstruction. Am Rev Respir Dis 99:865–871PubMed
25.
go back to reference Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR (2004) The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23:28–33PubMedCrossRef Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR (2004) The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23:28–33PubMedCrossRef
26.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto-Plata V, Cabral HJ (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012PubMedCrossRef Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto-Plata V, Cabral HJ (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012PubMedCrossRef
27.
go back to reference Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R, Research Group NETT (2006) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173:1326–1334PubMedCrossRef Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R, Research Group NETT (2006) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173:1326–1334PubMedCrossRef
28.
go back to reference Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598–604PubMedCrossRef Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598–604PubMedCrossRef
Metadata
Title
Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation
Authors
Ernesto Crisafulli
Elena Venturelli
Gianluca Biscione
Guido Vagheggini
Andrea Iattoni
Sasha Lucic
Nicolino Ambrosino
Franco Pasqua
Alfredo Cesario
Enrico Maria Clini
Publication date
01-02-2014
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 1/2014
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0727-z

Other articles of this Issue 1/2014

Internal and Emergency Medicine 1/2014 Go to the issue

IM - CASE RECORD

A pain in the arms

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine